Skip to main navigation

Top bar

Biogen.com Information Request Sign up for Alerts Search

Investor Relations

Overview

News

Events Presentations

SEC Filings Annual Reports

Stock Quote & Chart Analyst Coverage Investor FAQs

Governance Documents Committee Composition & Charters Leadership Code of Business Conduct Contact the Board

News

News

News Category

Year

October 23, 2017

Biogen and Eisai Expand Existing Collaboration Agreement to Develop and Commercialize Investigational Alzheimer’s Disease Treatments Including Phase 3 Aducanumab

October 18, 2017

Biogen Confirms Commitment to Tackle Multiple Sclerosis Through Comprehensive Approach

October 5, 2017

Biogen’s SPINRAZA® (nusinersen) Data Show Earlier Treatment Initiation May Lead to Improved Motor Function Across a Broad Population of People Living with Spinal Muscular Atrophy

September 26, 2017

Biogen to Report Third Quarter 2017 Financial Results on October 24, 2017

September 25, 2017

Biogen Appoints Camille Lee as SVP, Alzheimer’s Disease Therapeutic Area

September 12, 2017

Biogen Appoints Sanjay Jariwala as SVP, Worldwide Medical

September 6, 2017

Biogen to Present at the Morgan Stanley 15th Annual Global Healthcare Conference

August 28, 2017

Biogen Reports New Data from Phase 1b Study of Investigational Alzheimer’s Disease Treatment Aducanumab

August 24, 2017

IMRALDI®, Biogen’s Adalimumab Biosimilar Referencing Humira®, is Approved in the European Union

July 31, 2017

Biogen Appoints Anabella Villalobos Senior Vice President, Biotherapeutic & Medicinal Sciences

Pagination

First page
Previous page
…
Page 3
Page 4
Page 5
Page 6
Current page 7
Page 8
Page 9
Page 10
Page 11
…
Next page
Last page

Displaying 61 - 70 of 631

Footer

Investors
Careers
Our Stories
Contact Us

Follow us

Bottom

Privacy Policy
Terms & Conditions
Forward-Looking Statements
Community Guidelines

Investor Relations

Overview

News

Events & Presentations

Events
Presentations

Financials

SEC Filings
Annual Reports

Stock Information

Stock Quote & Chart
Analyst Coverage
Investor FAQs

Corporate Governance

Governance Documents
Committee Composition & Charters
Leadership
Code of Business Conduct
Contact the Board

Top bar

Biogen.com

Information Request

Sign up for Alerts

Search

Follow us